(Q48266103)

10 February 2018

title

Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab (English)

1 reference

10 February 2018

progressive multifocal leukoencephalopathy

main subject

0 references

author name string

Eavan M Mc Govern

series ordinal

1

1 reference

10 February 2018

Michael J Hennessy

series ordinal

2

1 reference

10 February 2018

publication date

5 December 2012

1 reference

10 February 2018

published in

Journal of Neurology

1 reference

10 February 2018

volume

260

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

665-667

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-012-6759-0

exact match

0 references

cites work

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6759-0

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6759-0

MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6759-0

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6759-0

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23212753

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Progressive multifocal leukoencephalopathy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23212753

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-012-6759-0

1 reference

10 February 2018

1 reference

10 February 2018